Andrew P Jewell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrew P Jewell has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Rachel Garrod
King's College London, Denmark Hill Campus, London, UK
2 shared publications - Agnieszka Lewko
Faculty of Health, Social Care and Education, St. George's University of London and Kingston University, UK
1 shared publication - Gill Mein
Faculty of Health, Social Care and Education, St George's University of London, London, United Kingdom
1 shared publication - Ken A. van Someren
English Institute of Sport, London, UK
1 shared publication - Kwee L. Yong
University College London
1 shared publication - Lara Groeneveldt
Cancer Institute, University College London, 72 Huntley Street, WC1E 6DD, London, UK
1 shared publication
Latest Publications
- 1 January 2014
- Published by Elsevier in Respiratory Medicine
- Vol. 108 (1) , 95-102
Evaluation of multidimensional COPD-related subjective fatigue following a Pulmonary Rehabilitation programme
- 1 January 2014
- Published by Elsevier in Respiratory Medicine
- Vol. 108 (1) , 95-102
Evaluation of multidimensional COPD-related subjective fatigue following a Pulmonary Rehabilitation programme
- Open Access
- 24 January 2013
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 31
A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors
Background: Exercise programmes are beneficial for cancer patients however evidence is limited in patients with multiple myeloma (MM), a cancer that is characterised by osteolytic bone disease, giving rise to high levels of bone morbidity including fractures and bone pain. Methods: We conducted a single arm phase 2 study of an exercise programme (EP) as rehabilitation for treated MM patients, to evaluate feasibility, effects on QOL and physiological parameters. Patients were given individualised programmes, comprising stretching, aerobic and resistance exercises, carried out under supervision for 3 months then at home for a further 3 months. Results: Study uptake was high, 60 of 75 (80%) patients approached consented to the study. Screen failures (11, due to fracture risk and disease relapse) and patient withdrawals (12) resulted in a final 37 patients enrolling on the programme. These 37 patients demonstrated high attendance rates in the supervised classes (87%), and high levels of adherence in home exercising (73%). Patients reported better QOL following the EP, with improvement in FACT-G and Fatigue scores over time from baseline (p<0.01 for both, one-way repeated measures ANOVA) to 6 months. Upper and lower limb strength also improved on the EP, from baseline to 6 months (p<0.01 for both). There were no adverse reactions. Conclusions: An EP in MM patients is feasible and safe, with high attendance and adherence. Benefits in QOL, fatigue and muscle strength await confirmation in randomized studies, prompting urgent evaluation of the benefits of EP in the rehabilitation of MM patients.
- 24 January 2013
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 31
Open AccessA mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors
Background: Exercise programmes are beneficial for cancer patients however evidence is limited in patients with multiple myeloma (MM), a cancer that is characterised by osteolytic bone disease, giving rise to high levels of bone morbidity including fractures and bone pain. Methods: We conducted a single arm phase 2 study of an exercise programme (EP) as rehabilitation for treated MM patients, to evaluate feasibility, effects on QOL and physiological parameters. Patients were given individualised programmes, comprising stretching, aerobic and resistance exercises, carried out under supervision for 3 months then at home for a further 3 months. Results: Study uptake was high, 60 of 75 (80%) patients approached consented to the study. Screen failures (11, due to fracture risk and disease relapse) and patient withdrawals (12) resulted in a final 37 patients enrolling on the programme. These 37 patients demonstrated high attendance rates in the supervised classes (87%), and high levels of adherence in home exercising (73%). Patients reported better QOL following the EP, with improvement in FACT-G and Fatigue scores over time from baseline (p<0.01 for both, one-way repeated measures ANOVA) to 6 months. Upper and lower limb strength also improved on the EP, from baseline to 6 months (p<0.01 for both). There were no adverse reactions. Conclusions: An EP in MM patients is feasible and safe, with high attendance and adherence. Benefits in QOL, fatigue and muscle strength await confirmation in randomized studies, prompting urgent evaluation of the benefits of EP in the rehabilitation of MM patients.